Clinical trial
A Clinical Trial To Assess Fesoterodine On Treatment Satisfaction And Symptom…
NCT00425100 · Pfizer, Industry · Completed
Key facts
| NCT number | NCT00425100 |
|---|---|
| Title | A Clinical Trial To Assess Fesoterodine On Treatment Satisfaction And Symptom Improvement In Overactive Bladder Patients |
| Official title | A 12-Week, Multicenter, Open-Label, Single-Arm Study To Evaluate The Effects Of Fesoterodine On Treatment Satisfaction And Symptom Relief In Overactive Bladder Patients. |
| Lead sponsor | Pfizer, Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Overactive Bladder |
| Intervention type | Drug |
| Interventions | fesoterodine fumarate |
| Enrollment | 516 |
| Start date | Jan 1, 2007 |
| Primary completion | Oct 1, 2007 |
| Completion | Oct 1, 2007 |
| First posted | Jan 22, 2007 |
| Last update posted | Dec 5, 2018 |
| Countries | Belgium, Costa Rica, Czechia, Germany, Poland, Slovakia, South Korea, Ukraine, United States |
At a glance
- 10–99 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: